References

1.      Duffy, S.W., Tabar, L., & Chen, T.H.H. (2006). Reduction in breast cancer mortality from organized service screening with mammography: Further confirmation with extended data. Cancer Epidemiol Biomarkers Pre, 15, 45-51.

2.      Saslow, D., Boetes, C., Burke, W., et al. (2007). American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography. CA Cancer J Clin, 57, 75-89.

3.      Drew, P.J., Chatterjee, S., Turnbull, L.W., et al. (1999). Dynamic contrast enhanced magnetic resonance imaging of the breast is superior to triple assessment for the pre-operative detection of multifocal breast cancer. Ann Surg Oncol, 6, 599-603.

4.      Heywang-Kobrunner, S.H., Viehweg, P., Heinig, A., et al. (1997). Contrast-enhanced MRI of the breast: Accuracy, value, controversies, solutions. Eur J Radiol, 24, 94-108.

5.      Feig, S.A. (2000). Ductal carcinoma in situ: implications for screening mammography. Radiol Clin North Am, 38, 653-68.

6.      Orel, S.G., Mendonca, M.H., Reynolds, C., et al. (1997). MR imaging of ductal carcinoma in situ. Radiology, 202, 413-20.

7.      Ikeda, D.M., Birdwell, R.L., & Daniel, B.L. (2001). Potential role of magnetic resonance imaging and other modalities in ductal carcinoma in situ detection. MRI Clin North Am, 9, 345-56.

8.      Berg, W.A., Gutierrez, L., NessAiver, M.S., et al. (2004). Diagnostic accuracy of mammography, clinical examination, US, and MR imaging in preoperative assessment of breast cancer. Radiology, 233, 830-49.

9.      Davis, P.L., Staiger, M.J., Harris, K.B., et al. (1996). Breast cancer measurements with magnetic resonance imaging, ultrasonography, and mammography. Breast Cancer Rest Treat, 37, 1-9.

10.  Morrow, M. (2004). Magnetic resonance imaging in breast cancer: One step forward, two steps back? JAMA, 292, 2779-80.

11.  Mollick, J.A., & Carlson, R.W. (2004). Rational surveillance programs for early stage breast cancer patients after primary treatment. Breast Dis, 21, 47-54.

12.  Birdwell, R.L., & Smith, D.N. (2005). MR imaging use in breast cancer staging and assessment of treatment [In] 2005 Syllabus, Categorical Course in Diagnostic Radiology: Breast imaging [Ed by] Feig, S.A., Oakbrook, Ill. Radiological Society of North America, 199-208.

13.  Tillman, G.F., Orel, S.G., Schnall, M.D., et al. (2002). Effect of magnetic resonance imaging on the clinical management of women with early-stage breast carcinoma. J Clin Oncol, 20, 3413-23.

14.  Bedrosian, I., Mick, R., Orel, S.G., et al. (2005). Changes in the surgical management of patients with breast carcinoma based on pre-operative magnetic resonance imaging. Cancer, 98, 468-73.

15.  Weatherall, P.T., Evans, G.F., Metzger, G.J., et al. (2001). MRI vs. histologic measurement of breast cancer following chemotherapy: Comparison with x-ray mammography and palpation. J Magn Reson Imaging, 12, 868-75.

16.  Reiben, A., Brambo, H.J., Gabelman, A., et al. (2002). Breast MRI for monitoring response of primary breast cancer to neoadjuvant chemotherapy. Eur J Radiol, 12, 1711-19.

17.  Rosen, E.L., Blackwell, K.L., Baker, J.A., et al. (2003). Accuracy of MR in the detection of residual breast cancer after neoadjuvant chemotherapy. Am J Roentgenol, 181, 1275-82.

18.  Lehman, C.D., et al. (2007). MRI evaluation of the contralateral breast in women with recently diagnosed breast cancer. N Eng J Med, 356, 1295-1303.